XHANCE is the first and only approved treatment for people suffering from chronic sinusitis without nasal polyps. Doctors emphasize that this system is considered very safe for most patients. As with ...

LYRA skyrockets 356% after its lead nasal implant, LYR-210, meets key goals in a pivotal phase III chronic rhinosinusitis study.

In patients with chronic rhinosinusitis with nasal polyps, factors including baseline antibiotic use and asthma impacted the ...

An estimated 30 million American adults grapple with the discomfort of chronic sinusitis, a condition that makes the simple act of breathing a challenge for about one in eight adults.

Shares of Lyra Therapeutics, Inc. (LYRA) rocketed 370% on Monday after the company announced positive results from its ...

Lyra also reported success on key secondary endpoints. These included improvements in broader symptom scores and patient ...

Lyra's LYR-210 met key goals in a Phase 3 trial for chronic rhinosinusitis, showing early and sustained symptom relief with a ...

The TikToker claimed that her bare-butted significant other at the time let out a particularly smelly fart that led chronic ...

Market Overview: The Global Nasal Polyposis Drugs Market is expanding rapidly, owing to advances in biologic medicines, minimally invasive surgical procedures, and personalized medicine approaches.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) on Friday announced results from two Phase 3 trials ...

As respiratory diseases are more common in winter, preventive measures can help reduce the risk of developing sinusitis. These include washing hands frequently to prevent viral infections that lead to ...

Real Housewives Of Cheshire star Leilani Dowding has revealed she is currently in hospital after undergoing planned septal ...